Provident Investment Management, Inc. Novo Nordisk A S Transaction History

Provident Investment Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $420,343 - $478,122	-10,119 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$44.29 - $50.42 $5,270 - $5,999	119 Added 1.19%	10,119 $467,000
Q1 2018 Apr 23, 2018	BUY	$48.49 - $58.14 $484,900 - $581,400	10,000 New	10,000 $493,000

1,991

318M

5.23M

4.97M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $273B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Provident Investment Management, Inc. with notifications on news.